ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q4Scopus Q3SCImago #11,202Hybrid

Stem Cells and Development

Abbreviation (ISO):STEM CELLS DEV
•
Identifier (ISSN):1547-3287(Print)
•
Publisher:Mary Ann Liebert Inc.
Clarivate IF (2026)
1.9↓ -0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Stem Cells and Development

WoS Q4
13463.3120183.1520193.0820203.2720214.392022420232.52024220251.92026
Annual Impact Factor Metric
Current (2026):1.9
Scopus SJR & RankScopus Q3
0.532
#11,202

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
142

142 papers with at least that number of citations each

WoS: SCIE / JCRQ4
Self-Citation Rate4%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
96articles/year
11.24% Gold OA•98.41% Original Research

Aims & Scope

Stem Cells and Development is globally recognized as the trusted source for critical, even controversial coverage of emerging hypotheses and novel findings. With a focus on stem cells of all tissue types and their potential therapeutic applications, the Journal provides clinical, basic, and translational scientists with cutting-edge research and findings. Stem Cells and Development coverage includes: Embryogenesis and adult counterparts of this process Physical processes linking stem cells, primary cell function, and structural development Hypotheses exploring the relationship between genotype and phenotype Development of vasculature, CNS, and other germ layer development and defects Pluripotentiality of embryonic and somatic stem cells The role of genetic and epigenetic factors in development

Topics Covered (Recognized by AI)
Biology99.8%Genetics96.7%Cell biology93.8%Chemistry88.6%Biochemistry88.2%Medicine83.9%Stem cell75.2%Gene67.5%Internal medicine67.1%Pathology52.2%Immunology48.5%In vitro43.1%Embryonic stem cell41.6%Mesenchymal stem cell34.9%Cellular differentiation33.2%Cell31.2%Endocrinology29.5%Cancer research29.3%Progenitor cell24.5%Induced pluripotent stem cell22.7%Molecular biology21%Endothelial stem cell20.5%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

CELL & TISSUE ENGINEERING

Q4
Rank29/32
IndexSCIE
JCRSCIE2026

HEMATOLOGY

Q3
Rank69/103
IndexSCIE
JCRSCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Q3
Rank129/191
IndexSCIE
JCRSCIE2026

TRANSPLANTATION

Q3
Rank18/30
IndexSCIE
JCISCIE2026

CELL & TISSUE ENGINEERING

Q3
Rank19/32
IndexSCIE
JCISCIE2026

HEMATOLOGY

Q2
Rank47/103
IndexSCIE
JCISCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Q3
Rank104/191
IndexSCIE
JCISCIE2026

TRANSPLANTATION

Q3
Rank18/30
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF1.9
Articles / Year36
Total Citations6
2025
IF2
Articles / Year47
Total Citations91
2024
IF2.5
Articles / Year61
Total Citations248
2023
IF4
Articles / Year64
Total Citations355
2022
IF4.39
Articles / Year73
Total Citations660

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #11,202Scopus Q3SCImago Profile
Scopus Coverage:2004-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q3
0.532

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3
Citations / Doc (2 years)
2.00

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,147 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations385
3-Year Documents192
Citable Documents187

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate46.4%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Developmental BiologyQ3
HematologyQ3
Cell BiologyQ4
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 4%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区CELL & TISSUE ENGINEERING
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Stem Cells and Development (abbr: STEM CELLS DEV, ISSN: 1547-3287) is a peer-reviewed international scholarly journal in the field of Medicine, published by Mary Ann Liebert Inc. in United States since 2004. The periodical holds a Journal Impact Factor (JIF) of 1.90, ranking in quartile Q4 of Web of Science (SCIE), a Scopus SJR indicator of 0.532 (Q3), an H-index of 142.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 96 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,147 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Mary Ann Liebert Inc.
Publication Language
English
Frequency
Bimonthly
Founding Year
2004
Indexing & Databases
SCIEScopusPubMed
Editorial Address
MARY ANN LIEBERT INC, 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, USA, NY, 10801

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: d7099ed4-1d03-4b66-96bd-93a499cd328c
Database Updated: 2026-09-28